Proventil drug class
Pro Research Analysisby 
Searched over 200M research papers
Proventil Drug Class: An Overview
Introduction to Proventil and Its Drug Class
Proventil, also known by its generic name albuterol, is a medication primarily used to treat and prevent bronchospasm in patients with reversible obstructive airway disease, such as asthma. It belongs to the drug class known as beta2-adrenergic agonists, which work by relaxing the muscles in the airways and increasing airflow to the lungs.
Bronchodilator Effectiveness of Proventil
Comparable Efficacy to Ventolin
Research has shown that Proventil HFA (hydrofluoroalkane) provides bronchodilation comparable to Ventolin, another commonly used albuterol inhaler. In a 12-week study, both Proventil HFA and Ventolin demonstrated similar effectiveness in improving lung function, as measured by forced expiratory volume in one second (FEV1) . This study highlighted that both medications are effective in managing asthma symptoms over a prolonged period.
Protection Against Bronchoconstriction
Proventil HFA has also been shown to be bioequivalent to Ventolin-CFC (chlorofluorocarbon) in protecting against methacholine-induced bronchoconstriction. This was demonstrated in a study where the relative potency of Proventil HFA was found to be similar to that of Ventolin-CFC, indicating that both formulations are equally effective in preventing bronchoconstriction .
Safety Profile of Proventil
Similar Safety to Ventolin
The safety profile of Proventil HFA is comparable to that of Ventolin. In a randomized, double-blind study, adverse event reporting rates were similar for both Proventil HFA and Ventolin, with no significant differences in heart rate, blood pressure, or laboratory test results . This indicates that Proventil HFA is well-tolerated and safe for regular use in asthmatic patients.
Extended-Release Formulations
Proventil is also available in extended-release formulations, such as Proventil Repetabs. Studies comparing Proventil Repetabs to other extended-release albuterol products, like Volmax, have shown that Proventil Repetabs provide effective bronchodilation with a controlled release of the medication, ensuring consistent therapeutic effects throughout the day .
Conclusion
Proventil, a beta2-adrenergic agonist, is an effective and safe medication for managing asthma and other obstructive airway diseases. Its bronchodilator effects are comparable to those of Ventolin, and it offers a similar safety profile. Extended-release formulations of Proventil provide additional options for patients requiring consistent bronchodilation. Overall, Proventil remains a reliable choice for asthma management.
Sources and full results
Most relevant research papers on this topic
Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Proventil HFA provides bronchodilation comparable to Ventolin and superior to HFA-134a placebo over 12 weeks of regular dosing, but response diminishes after 4 weeks.
Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
Proventil-HFA salbutamol is bioequivalent to Ventolin-CFC salbutamol, with 100- and 200-microgram doses being sufficient for bronchoprotection against methacholine bronchoconstriction.
Albuterol Extended‐Release Products: A Comparison of Steady‐State Pharmacokinetics
Volmax provides a more controlled release of albuterol during both daytime and nighttime dosing intervals than Proventil Repetabs, with no significant differences in adverse experiences.
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials
AS MDI 180 g is an equivalent dose to Proventil for bronchodilation in patients with asthma, supporting its selection for Phase III clinical trials.
Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin.
Proventil HFA provides comparable protection against exercise-induced bronchoconstriction to Ventolin and Proventil, with a safer profile compared to placebo.
DOI
The effect of a holding chamber on albuterol metered-dose inhaler product differences.
Ventolin, Proventil, and ProAir are not interchangeable products, with Proventil or ProAir providing 2 to 3 times the dose of albuterol sulfate likely to reach the lungs compared to Ventolin, requiring 3 additional puffs for similar clinical benefit.
DOI